Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S, Bertolo R, Campi R, Capitanio U, Amparore D, Anceschi U, Mir MC, Roussel E, Pavan N, Carbonara U, Kara O, Klatte T, Marchioni M, Pecoraro A, Muselaers S, Marandino L, Diana P, Borregales L, Palumbo C, Warren H, Wu Z, Calio A, Ciccarese C, Degirmenci E, Aydin R, Rebez G, Schips L, Simone G, Minervini A, Serni S, Ozcan F. Erdem S, et al. Among authors: diana p. Urol Oncol. 2024 May;42(5):163.e1-163.e13. doi: 10.1016/j.urolonc.2024.01.028. Epub 2024 Mar 5. Urol Oncol. 2024. PMID: 38443238
The impact of ischemic injury in patients with solitary kidneys: new cornerstones for contemporary "precision" robot-assisted partial nephrectomy.
Diana P, Muselaers S, Kara O, Pavan N, Pecoraro A, Carbonara U, Campi R, Amparore D; EAU Young Academic Urologists (YAU) Renal Cancer working group. Diana P, et al. Minerva Urol Nephrol. 2021 Dec;73(6):851-853. doi: 10.23736/S2724-6051.21.04810-2. Minerva Urol Nephrol. 2021. PMID: 35144369 Free article. No abstract available.
Screening programs for renal cell carcinoma: a systematic review by the EAU young academic urologists renal cancer working group.
Diana P, Klatte T, Amparore D, Bertolo R, Carbonara U, Erdem S, Ingels A, Kara O, Marandino L, Marchioni M, Muselaers S, Pavan N, Pecoraro A, Pecoraro A, Roussel E, Campi R; European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer group. Diana P, et al. World J Urol. 2023 Apr;41(4):929-940. doi: 10.1007/s00345-022-03993-6. Epub 2022 Apr 1. World J Urol. 2023. PMID: 35362747 Free PMC article.
Are nephrometry scores accurate for the prediction of outcomes in patients with renal angiomyolipoma treated with robot-assisted partial nephrectomy? A multi-institutional analysis.
Uleri A, Diana P, Lughezzani G, Casale P, Saita A, Hurle R, Lazzeri M, Porpiglia F, Fiori C, Amparore D, Verri P, Rosiello G, Mottrie A, DE Naeyer G, DE Groote R, Porter J, Buffi N. Uleri A, et al. Among authors: diana p. Minerva Urol Nephrol. 2022 Dec;74(6):730-737. doi: 10.23736/S2724-6051.22.04848-0. Epub 2022 May 27. Minerva Urol Nephrol. 2022. PMID: 35622350 Free article.
Oncological safety of partial nephrectomy for pT3a renal cell carcinoma: reading between the lines.
Campi R, Diana P, Muselaers S, Erdem S, Marchioni M, Ingels A, Kara Ö, Carbonara U, Pavan N, Marandino L, Roussel E, Bertolo R; EAU Young Academic Urologists (YAU) Renal Cancer Working Group. Campi R, et al. Among authors: diana p. Minerva Urol Nephrol. 2022 Aug;74(4):488-491. doi: 10.23736/S2724-6051.22.05017-0. Minerva Urol Nephrol. 2022. PMID: 35848343 Free article. No abstract available.
Small renal masses in kidney transplantation: Overview of clinical impact and management in donors and recipients.
Piana A, Andras I, Diana P, Verri P, Gallioli A, Campi R, Prudhomme T, Hevia V, Boissier R, Breda A, Territo A; European Association of Urology (EAU) Young Academic Urologists (YAU) Kidney Transplantation Working Group, Arnhem, Netherlands. Piana A, et al. Among authors: diana p. Asian J Urol. 2022 Jul;9(3):208-214. doi: 10.1016/j.ajur.2022.06.001. Epub 2022 Jun 10. Asian J Urol. 2022. PMID: 36035353 Free PMC article. Review.
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
Marchioni M, Amparore D, Marandino L, Bertolo R, Erdem S, Ingels A, Muselaers S, Kara O, Pavan N, Roussel E, Carbonara U, Pecoraro A, Diana P, Pecoraro A, Campi R; European Association of Urology Young Academic Urologists Renal Cancer Working Group. Marchioni M, et al. Among authors: diana p. Eur Urol Open Sci. 2022 Oct 25;46:39-42. doi: 10.1016/j.euros.2022.10.002. eCollection 2022 Dec. Eur Urol Open Sci. 2022. PMID: 36325369 Free PMC article. No abstract available.
Cryoablation of small renal masses in patients with solitary kidneys: worth crossing the road for?
Bertolo R, Amparore D, Diana P, Erdem S, Marandino L, Carbonara U, Borregales LD, Muselaers S, Pavan N, Pecoraro A, Roussel E, Pecoraro A, Marchioni M, Campi R; EAU Young Academic Urologists (YAU) Renal Cancer working group. Bertolo R, et al. Among authors: diana p. Minerva Urol Nephrol. 2022 Dec;74(6):794-798. doi: 10.23736/S2724-6051.22.05184-9. Minerva Urol Nephrol. 2022. PMID: 36629808 Free article. No abstract available.
Optimizing postoperative follow-up in RCC patients: why does it always have to be black and white?
Muselaers S, Amparore D, Bertolo R, Diana P, Erdem S, Marandino L, Carbonara U, Borregales LD, Pavan N, Pecoraro A, Roussel E, Pecoraro A, Campi R, Marchioni M. Muselaers S, et al. Among authors: diana p. Minerva Urol Nephrol. 2022 Dec;74(6):822-824. doi: 10.23736/S2724-6051.22.05211-9. Minerva Urol Nephrol. 2022. PMID: 36629817 Free article. No abstract available.
247 results